IP Library Granted Patent US 8,940,798
Granted Patent B2
US 8,940,798 · App. 13/668,714 · Granted Jan 27, 2015

Compounds useful for treating and/or preventing disease-associated bone loss

Inventor: Anne Blangy (Montpellier, FR)
Assignees: Centre National de la Recherche Scientifique (CNRS); Universite Montpellier 2 Sciences et Techniques
A61K31/145A61K31/18
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,940,798
App. No.
13/668,714
Granted
Jan 27, 2015
Kind
B2
Abstract

The present invention concerns a method for treating and/or preventing a disease in a subject comprising the step of administrating an effective amount of a compound of formula I to a subject in need thereof.

Claims (9)

1. A method for treating a disease comprising the step of administrating an effective amount of N-(3,5-dichloro phenyl)benzenesulfonamide to a subject in need thereof,

wherein the disease is menopause, osteoporosis, osteopenia due to bone metastases, periarticular erosions in rheumatoid arthritis, primary hyperparathyroidistn, hypercalcemia of malignancy, Paget's disease of hone, periodontal disease, immobilization induced osteopenia or bone metastasis.

2. The method according to claim 1 , wherein the disease is osteoporosis.

3. The method according to claim 1 , wherein the subject is under a glucocorticoid treatment.

4. The method according to claim 1 , wherein the subject is a postmenopausal woman.

5. The method according to claim 1 , wherein the subject has bone metastases.

6. The method according to claim 1 , wherein the subject is a mammal selected from the group consisting of: rodent, cat, dog, primate and human.

7. The method according to claim 1 , wherein said N-(3,5-dichloro phenyl)benzenesulfonamide is administered at concentration from 2 mg/D/kg to 50 mg/D/kg.

8. A pharmaceutical composition comprising N-(3,5-dichloro phenyl)benzenesulfonamide, and, optionally, a pharmaceutically acceptable support.

Assignments (2)
MERGER Recorded Jan 23, 2019
From: UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES
To: UNIVERSITE DE MONTPELLIER
Reel/Frame 048117/0670 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 10, 2014
From: BLANGY, ANNE
To: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS); UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES
Reel/Frame 034461/0587 →
Continuity (2)
Provisional Application 61555721 · Nov 4, 2011
Related Publication 20130165523A1 · Jun 27, 2013